← All Pulmonx CORP filings

Pulmonx CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
LUNG
Pulmonx CORP
10-K: Pulmonx Corporation Reports FY2024 Results: Revenue Up, Losses Narrow
Pulmonx Corporation's FY2024 shows increased revenue and a reduced net loss compared to the previous year, driven by growth in Zephyr Valve procedure volumes.
NASDAQ
LUNG
Pulmonx CORP
10-K: Pulmonx Corporation Reports 2023 Financial Results, Revenue Up 28%
Pulmonx Corporation's 2023 annual report reveals a 28% increase in revenue, reaching $68.7 million, alongside a net loss of $60.8 million.